Stephan Stilgenbauer¹, Barbara F. Eichhorst², Raymonde Busch^3*, Thorsten Zenz^1*, Dirk Winkler^1*, Andreas Bühler^1*, Valentin Goede^2*, Clemens M Wendtner^2*, Peter Lichter^4*, Berthold Emmerich^5*, Michael Hallek² and Hartmut Döhner^1*

¹Internal Medicine III, University of Ulm, Ulm, Germany
²Dept. of Internal Med. I, University of Cologne, Cologne, Germany
³Technical University, Institute for Medical Statistic and Epidemiology, Munich, Germany
⁴Division Molecular Genetics, German Cancer Research Center (DKFZ), Heidelberg, Germany
⁵Oncology Practice, Munich, Germany

Constantine S. Tam¹, William G. Wierda, M.D., Ph.D², Susan O'Brien³, Susan Lerner^3*, Issa F Khouri^4*, Hagop M. Kantarjian^3* and Michael J Keating, M.D.^3*

¹Haematology, St Vincent's Hospital, Fitzroy, Australia
²Leukemia, UT M. D. Anderson Cancer Center, Houston, TX
³Leukemia, UT MD Anderson Cancer Center, Houston, TX
⁴Stem Cell Transplantation and Cellular Therapy, UT MD Anderson Cancer Center, Houston, TX

Wolfgang Ulrich Knauf¹, Toshko Lissitchkov^2*, Ali Aldaoud^3*, Anna Liberati^4*, Javier Loscertales^5*, Roul Herbrecht^6*, Gunnar Juliusson, MD⁷, Gerhard Postner^8*, Liana Gercheva^9*, Stefan Goranov, MD¹⁰, Martin Becker^11*, Klaus Hoeffken^12*, Francoise Huguet^13*, Robert Foa, MD¹⁴, Karlheinz Merkle¹⁵ and Marco Montillo¹⁶

¹Onkologische Praxis Frankfurt, Frankfurt, Germany
²Hematology & Transfusion Medicine, National Hematological Center, Sofia, Bulgaria
³Onkologische Gemeinschaftspraxis, Leipzig, Germany
⁴Dept. Oncology, Universita degli Studi, Perugia, Italy
⁵Dept. Hematology, Hopital de la Princesa, Madrid, Spain
⁶Dept. Hematology & Oncology, Hopital de Hautepierre, Strasbourg, France
⁷Dept. of Hematology, Lund Stem Cell Center, Lund, Sweden
⁸3rd Medical Department, Kaiser Franz Josef Spital, Vienna, Austria
⁹Dept. Hematology, University Hospital, Varna, Bulgaria
¹⁰University Hospital for Active Treatment "St. George", Plovdiv, Bulgaria
¹¹Onkologische Schwerpunktpraxis, Porta Westphalika, Germany
¹²Dept. Hematology & Oncology, University Hospital, Jena, Germany
¹³Dept. Hematology, Hopital de Purpan, Toulouse, France
¹⁴Dept. of Cellular Biotechnologies & Hematology, University 'La Sapienza', Rome, Italy
¹⁵Oncology Consulting, Miesbach, Germany
¹⁶Divisione Ematologia, Ospedale Niguarda, Milano, Italy

Krzysztof Giannopoulos^1*, Anna Dmoszynska², Malgorzata Kowal^2*, Ewa Wasik-Szczepanek^2*, Paulina Wlasiuk^2*, Agnieszka Bojarska-Junak^1*, Jacek Rolinski^1*, Hartmut Döhner^3*, Stephan Stilgenbauer^3* and Lars Bullinger^3*

¹Clinical Immunology, Medical University of Lublin, Lublin, Poland
²Hematooncology, Medical University of Lublin, Lublin, Poland
³Internal Medicine III, University of Ulm, Ulm, Germany

Michael J. Keating, M.B., B.S.¹, Susan Lerner^1*, Xuemei Wang^2*, Laura Z. Rassenti, Ph.D.³, Susan O'Brien, M.D.¹, Thomas J. Kipps, M.D., Ph.D.³ and William G. Wierda, M.D., Ph.D¹

¹Leukemia, UT M. D. Anderson Cancer Center, Houston, TX
²Quantitative Sciences Division, UT M. D. Anderson Cancer Center, Houston, TX
³Moores Cancer Center, University of California, San Diego, San Diego, CA

William G Wierda, MD, PhD¹, Susan M O'Brien, MD¹, Xuemei Wang, MS^2*, Stefan H Faderl, MD^1*, Alessandra Ferrajoli, MD¹, Guillermo Garcia-Manero, MD^1*, Jorge Cortes, MD¹, Constantine S Tam, MBBS³, Jan A Burger, MD, PhD¹, Lynne V Abruzzo, MD, PhD⁴, Ellen Schlette, MD⁴, Susan Lerner^1* and Michael J Keating, MBBS¹

¹Leukemia, U.T.M.D. Anderson Cancer Center, Houston, TX
²Quantitative Sciences Division, U.T.M.D. Anderson Cancer Center, Houston, TX
³Haematology, St Vincent's Hospital, Fitzroy, Australia
⁴Hematopathology, U.T.M.D. Anderson Cancer Center, Houston, TX

William G Wierda, MD, PhD, Susan M O'Brien, MD, Stefan H Faderl, MD, Alessandra Ferrajoli, MD, Charles Koller, MD^*, Zeev Estrov, MD^*, Jan A Burger, MD, PhD, Susan Lerner^*, Hagop M. Kantarjian, MD and Michael J Keating, MBBS

Leukemia, U.T.M.D. Anderson Cancer Center, Houston, TX

Silvia Deaglio¹, Semra Aydin^1*, Tiziana Vaisitti^1*, Luciana Bergui^2*, Giovanni D'Arena^3*, Lisa Bonello^4*, Ifigenia Saborit^1*, Davide Rossi⁵, Gianluca Gaidano^5*, Giovanna Chiorino^6* and Fabio Malavasi^1*

¹Department of Genetics, Laboratory of Immunogenetics, University of Turin, Turin, Italy
²Division of Hematology, University of Turin, Turin, Italy
³IRCCS San Giovanni Rotondo, San Giovanni Rotondo (FG), Italy
⁴CeRMS, University of Turin, Turin, Italy
⁵Division of Hematology, Department of Clinical and Experimental Medicine, University of Eastern Piedmont, Novara, Italy
⁶Fondo Edo Tempia, Biella, Italy

Francesc Bosch, MD, PhD¹, Pau Abrisqueta, MD^2*, Neus Villamor, MD, PhD^2*, Maria Jose Terol, MD^2*, Josep-Maria Ribera, MD^2*, Eva Gonzalez-Barca, MD^2*, Marcos Gonzalez, MD^2*, Eugenia Abella, MD^2*, Julio Delgado, MD^2*, Yolanda Gonzalez, MD^2*, Secundino Ferrer, MD^2*, Felix Carbonell, MD^2*, Lourdes Escoda, MD^2*, Isidro Jarque, MD^2*, Encarnacion Monzo, MD^2*, Ana Muntañola, MD^2*, Olga Salamero, MD^2* and Emili Montserrat, MD^2*

¹Institute of Hematology and Oncology. Departament of Hematology, Spanish CLL Group, IDIBAPS, Hospital Clinic Barcelona, Barcelona, Spain
²Spanish CLL Group, Barcelona, Spain

Olga Frankfurt, Elizabeth Hamilton^*, Sara Duffey^*, Simbi Acharya^*, Adekunle Raji^*, Shuo Ma^*, Loann Peterson^*, Charles Goolsby^* and Steven T. Rosen

Robert H. Lurie CCC, Northwestern University, Chicago, IL

Georg Aue, MD¹, Ndegwa Njuguna, MD^1*, Xin Tian, PhD^2*, Janet Valdez, PA^1*, Susan Soto, RN^1*, J. Philip McCoy Jr., PhD^3*, Leigh Samsel^3*, Berengere Vire, PhD^1*, Keyvan Keyvanfar^1*, Stefania Pittaluga, MD⁴ and Adrian Wiestner, MD, PhD¹

¹Hematology Branch, NHLBI, NIH, Bethesda, MD
²Office of Biostatistics Research, NHLBI, NIH, Bethesda, MD
³Flow Cytometry Core Facility, NHLBI, NIH, Bethesda, MD
⁴Laboratory of Pathology, NCI, NIH, Bethesda, MD

Januario Castro, MD¹, Jose D. Sandoval, MD^1*, Johanna Melo-Cardenas, B.Sc^1*, Denise Darrah, RN^1*, Mauricio Urquiza, PhD^1*, Charles Prussak, PhD² and Thomas J. Kipps, MD, PhD³

¹Moores Cancer Center, University of California, San Diego, San Diego, CA
²MemGen, LLC, Solana Beach, CA
³Moores Cancer Ctr., Univ. of California, San Diego, La Jolla, CA

Monica Else, MA, MSc^1*, Claire E. Dearden, MD², Estella Matutes, MD^1*, Ama Z S Rohatiner, MD³, Steve A N Johnson, MD^4*, Nigel T J O'Connor, MD^5*, Andy Haynes, MD^6*, Nnenna Osuji, MD^1* and Daniel Catovsky, MD, DSc(Med)⁷

¹Section of Haemato-Oncology, The Institute of Cancer Research, Sutton SM2 5NG, United Kingdom
²The Royal Marsden Hospital, Sutton, Surrey, United Kingdom
³St Bartholomew's Hospital, London, United Kingdom
⁴Taunton and Somerset Hospital, United Kingdom
⁵Royal Shrewsbury Hospital, United Kingdom
⁶Nottingham City Hospital, United Kingdom
⁷Section of Haemato-Oncology, The Institute of Cancer Research, London, United Kingdom

Sanne H. Tonino, MD^1*, Chantal Mulkens^1*, Yoshinori Nonomura, MD^2*, Guangli Suo, MD^2*, Thomas J. Kipps, MD, PhD³, Marinus H.J. van Oers, MD, PhD^1*, Eric Eldering, MD^4* and Arnon P. Kater, MD, PhD^5*

¹Department of Hematology, Academic Medical Center, Amsterdam, the Netherlands, Amsterdam, Netherlands
²Moores Cancer Center, University of California San Diego, La Jolla, CA
³Moores Cancer Ctr., Univ. of California, San Diego, La Jolla, CA
⁴Department of Hematology and Experimental Immunology, Academic Medical Center, Amsterdam, Netherlands
⁵Department of Hematology, Academic Medical Center and University of California San Diego, Amsterdam, Netherlands

Tadeusz Robak, MD, PhD¹, Jerzy Z Blonski^1*, Krzysztof Jamroziak^1*, Joanna Gora-Tybor^1*, Beata Stella-Holowiecka^2*, Lech Konopka^3*, Bernadeta Ceglarek^3*, Krzysztof Warzocha^4*, Ilona Seferynska^4*, Janusz Kloczko^5*, Jaroslaw Piszcz^5*, Malgorzata Calbecka^6*, Aleksandra Kostyra^6*, Jadwiga Dwilewicz-Trojaczek^7*, Elzbieta Wiater^7*, Anna Dmoszynska⁸, Malgorzata Kowal^8*, Krystyna Zawilska^9*, Alina Grzywacz^9*, Andrzej Hellmann, MD, PhD^10*, Andrzej Mital^11*, Andrzej Zdunczyk^12*, Jacek Dybowicz^12*, Kazimierz Kuliczkowski^13*, Stanislaw Potoczek^13*, Aleksander Skotnicki^14*, Maria Nowakowska-Domagala^15*, Krzysztof Lewandowski^16* and Kazimierz Sulek^17*

¹Department of Hematology, Medical University of Lodz, Lodz, Poland
²Dept. of Hematology and BMT, Silesian Medical University Hospital SPSKM, Katowice, Poland
³Institute of Hematology and Blood Transfusion, Warszawa, Poland
⁴Institute of Hematology and Blood Transfusion, Warsaw, Poland
⁵Dept. of Hematology, Bialystok Medical Academy, Bialystok, Poland
⁶Haematology, Provincial Hospital, Torun, Poland
⁷Department of Hematology and Oncology, Medical University of Warsaw
⁸Medical University of Lublin, Lublin, Poland
⁹Dept. of Internal Medicine, Strus Hospital, Poznan, Poland
¹⁰Department of Hematology, Medical University of Gdansk, Gdansk, Poland
¹¹Dept. of Hematology, Medical Academy, Gdansk, Poland
¹²Hematology, City Hospital, Krakow, Poland
¹³Dept. of Hematology, Medical Academy, Wroclaw, Poland
¹⁴Collegium Medicum, Uniwersytetu Jagielonskiego, Krakow, Poland
¹⁵Haematology, Oncological Hospital, Kielce, Poland
¹⁶Dept Hematol, Med Univ, Poznan, Poland
¹⁷Dept. of Clinical Hematology, Military Medical Institute, Warsaw, Poland

Clemens M Wendtner, MD^1*, Daruka Mahadevan, MD, PhD², Stephan Stilgenbauer, MD, PhD³, Olga Frankfurt, MD⁴, Adrian Bloor, PhD, MRCP, FRCPath^5*, Francesc Bosch, MD, PhD⁶, Lutz Uharek^7*, Marco Gobbi^8*, Richard R Furman, MD⁹, John G. Gribben, MD, DSc¹⁰, Eva K. Kimby, MD, PhD¹¹, Mikkael A. Sekeres, MD, MS¹², Larry D. Cripe, MD¹³, Elyane Lombardy^14*, Sheetal Shah^14*, Laure A Moutouh-de Parseval^14*, Asher Alban Chanan-Khan, MD¹⁵ and Robert D. Knight, MD¹⁴

¹Department I of Internal Medicine, Univeristy of Cologne, Cologne, Germany
²Arizona Cancer Center, Tucson, AZ
³Internal Medicine III, University of Ulm, Ulm, Germany
⁴Robert H. Lurie CCC, Northwestern Memorial Hospital, Chicago, IL
⁵Christie Hospital NHS Foundation Trust, Manchester, United Kingdom
⁶Dept. de Hematology, Hospital Clinic Barcelona, Barcelona, Spain
⁷Medical Clinic III - Hematology and Oncology, Charité University Medicine Berlin, Germany
⁸Clinical hematology, University of Genova Italy, Genova, Italy
⁹Department of Hematology/Oncology, Weill Cornell Medical College, New York, NY
¹⁰Medical Oncology, Barts and the London School of Medicine, London, United Kingdom
¹¹Hematology Center, Karolinska Institute, Stockholm, Sweden
¹²Hematologic Oncology and Blood Disorders R35, Cleveland Clinic, Cleveland, OH
¹³Indiana University Simon Cancer Center, Indianapolis, IN
¹⁴Celgene Corporation, Summit, NJ
¹⁵Roswell Park Cancer Inst., Buffalo, NY

Farrukh Awan, MD, MS¹, Neil E. Kay^2*, Melanie Davis^1*, Wenting Wu^2*, Nelson Leung^3*, Diane F. Jelinek^2*, Renee Tschumper^2*, Charla Secreto^2*, Thomas S. Lin^4*, Michael R Grever, MD^4*, Tait Shanafelt, MD², Clive S. Zent^2*, Timothy G. Call^2*, Nyla A. Heerema, PhD⁵, Gerard Lozanski^5*, John C. Byrd, MD⁴ and David Lucas, PhD⁶

¹Hematology/Oncology, The Ohio State University, Columbus, OH
²Mayo Clinic, Rochester, MN
³Hematology, Mayo Clinic, Rochester, MN
⁴The Ohio State University, Columbus, OH
⁵Ohio State University, Columbus, OH
⁶OSUCCC Bldg., Rm. 455, Ohio State University, Columbus, OH

Fatma V Okur, MD^1*, Eric Yvon, MS^1*, Gianpietro Dotti, MD^1*, George Carrum, MD^1*, Helen E. Heslop, MD¹, Malcolm K Brenner, MD, PhD^1*, Joseph C. Fratantoni, MD², Madhusudan V Peshwa, PhD^2* and Linhong Li, PhD^2*

¹Baylor College of Medicine, Center for Cell and Gene Therapy, Houston, TX
²MaxCyte, Gaithersburg, MD

Hui Gao, PhD^1*, Alessandra Ferrajoli, MD^2*, Evan N Cohen^1*, Bang-Ning Lee, PhD^3*, Sanda Tin, M.D.^1*, Susan O'Brien, M.D.⁴, William G. Wierda, M.D., Ph.D⁵, Zeev Estrov, M.D.^6*, Stefan Faderl, MD³, Michael J Keating, M.D.^7* and James M. Reuben, PhD⁸

¹Hematopathology, UT, M.D. Anderson Cancer Center, Houston, TX
²Department of Leukemia, M.D. Anderson Cancer Ctr., Houston, TX
³M.D. Anderson Cancer Center, Houston, TX
⁴Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX
⁵Leukemia, UT M. D. Anderson Cancer Center, Houston, TX
⁶Leukemia, UT, M.D. Anderson Cancer Center, Houston, TX
⁷Leukemia, UT MD Anderson Cancer Center, Houston, TX
⁸M.D. Anderson Cancer Center, University of Texas, Houston, TX

Wyndham H Wilson, MD, PhD¹, O. O'Connor, M.D.², Myron S. Czuczman, MD³, Ann LaCasce, MD⁴, J. Gerecitano, M.D., Ph.D.⁵, John P. Leonard, MD⁶, Anil Tulpule, MD⁷, Hao Xiong, Ph.D.^8*, Yi-Lin Chiu, Ph.D.^8*, Todd Busman, Ph.D.^8*, Raymond A. Knight, MBA^8*, Sari Enschede, M.D.^8*, Andrew Krivoshik, M.D., Ph.D.^8* and Rod Humerickhouse, M.D., Ph.D^8*

¹Center for Cancer Research, National Cancer Institute, Bethesda, MD
²Columbia Univ. Med. Ctr., New York, NY
³Roswell Park Cancer Institute, Buffalo, NY
⁴Dana-Farber Cancer Inst., Boston, MA
⁵Memorial Sloan-Kettering Cancer Ctr., New York, NY
⁶Division of Hem./Onc., Weill Cornell Medical College, New York, NY
⁷USC School of Medicine, Norris Cancer Center, Los Angeles, CA
⁸Abbott Laboratories, Abbott Park, IL

William G Wierda, MD, PhD¹, Thomas J Kipps, MD, PhD², Michael J Keating, MBBS¹, Jennifer R Brown, MD, PhD³, John G Gribben, MD, DSc⁴, Laura Z Rassenti, PhD², Andrew W Greaves^2*, Donna Neuberg, ScD⁵ and Susan M O'Brien, MD¹

¹Leukemia, U.T.M.D. Anderson Cancer Center, Houston, TX
²Moores Cancer Center, University of California, San Diego, San Diego, CA
³Dana-Farber Cancer Inst., Boston, MA
⁴Institute of Cancer, Centre for Medical Oncology, London
⁵Biostatistics and Computational Biology, Dana-Farber Cancer Inst., Boston, MA